What is Secukinumab?

Category: Prescription Drugs

Most popular types: Cosentyx

false

Secukinumab is type of immunosuppressant that helps in the treatment of psoriasis.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
0
None
6

Commonly reported side effects and conditions associated with Secukinumab

Side effect Patients

Dosages

Based on patients currently taking Secukinumab

Dosage Patients
300 mg monthly 2
150 mg monthly 1
300 mL weekly 1
22,500 mg every other week 1

Why patients stopped taking Secukinumab

Multiple reasons could be selected

Reason Patients
Did not seem to work 1
See 1 patient who's stopped taking Secukinumab

Duration

Currently taking Secukinumab

Duration Patients
6 months - 1 year 2
1 - 2 years 3

Stopped taking Secukinumab

Duration Patients
1 - 6 months 1
Adherence
Adherence Evaluations
Always 4
Usually 1
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 2
Not at all hard to take 4
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 4
Not specified 2

What people switch to and from

Patients started taking Secukinumab after stopping:

Treatment Patients
Adalimumab (Humira) 4
Infliximab (Remicade) 4
Apremilast (Otezla) 3
Ustekinumab (Stelara) 3
Clobetasol topical (Clobex) 1

Show all 8 treatments patients report switching from

Patients stopped taking Secukinumab and switched to:

Treatment Patients
Dimethyl fumarate (Tecfidera) 1
Last updated:
There are no evaluations for Secukinumab.